BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28539744)

  • 1. Biological Effects of Hesperetin on Interleukin-6/Phosphorylated Signal Transducer and Activator of Transcription 3 Pathway Signaling in Prostate Cancer PC3 Cells.
    Shirzad M; Heidarian E; Beshkar P; Gholami-Arjenaki M
    Pharmacognosy Res; 2017; 9(2):188-194. PubMed ID: 28539744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
    Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
    Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effects of ellagic acid on pSTAT3, pAKT, and pERK1/2 signaling pathways in prostate cancer PC3 cells.
    Eskandari E; Heidarian E; Amini SA; Saffari-Chaleshtori J
    J Cancer Res Ther; 2016; 12(4):1266-1271. PubMed ID: 28169238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and Anti-invasion Effects of Carvacrol on PC3 Human Prostate Cancer Cells through Reducing pSTAT3, pAKT, and pERK1/2 Signaling Proteins.
    Heidarian E; Keloushadi M
    Int J Prev Med; 2019; 10():156. PubMed ID: 32133074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.
    Jorvig JE; Chakraborty A
    Anticancer Drugs; 2015 Feb; 26(2):160-6. PubMed ID: 25243457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway.
    Zheng CL; Hou KZ; Wang AQ; Fang WX; Yu ST; Liang JE; Qi HY; Qu XJ; Liu YP; Che XF
    Chin J Integr Med; 2022 Jun; 28(6):524-530. PubMed ID: 32648126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
    Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
    Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase.
    Weber GF; Gaertner FC; Erl W; Janssen KP; Blechert B; Holzmann B; Weighardt H; Essler M
    J Immunol; 2006 Dec; 177(11):8266-72. PubMed ID: 17114505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.
    Su Y; Chen L; Yang J
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38357946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
    Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD
    J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
    Ding H; Sun Y; Hou Y; Li L
    Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
    Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
    World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
    Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
    Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.
    Sakai I; Miyake H; Terakawa T; Fujisawa M
    Cancer Sci; 2011 Apr; 102(4):769-75. PubMed ID: 21214673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycitein induces reactive oxygen species-dependent apoptosis and G0/G1 cell cycle arrest through the MAPK/STAT3/NF-κB pathway in human gastric cancer cells.
    Zang YQ; Feng YY; Luo YH; Zhai YQ; Ju XY; Feng YC; Wang JR; Yu CQ; Jin CH
    Drug Dev Res; 2019 Aug; 80(5):573-584. PubMed ID: 30916421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway.
    Cao H; Feng Y; Sun P; Chen L; Wang D; Gao R
    J Cancer; 2023; 14(12):2246-2254. PubMed ID: 37576403
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .
    Lou W; Ni Z; Dyer K; Tweardy DJ; Gao AC
    Prostate; 2000 Feb; 42(3):239-42. PubMed ID: 10639195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
    Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
    Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.